Ronald C Renaud Jr's Net Worth
$37 Million
Who is Ronald C Renaud Jr?
Ronald C Renaud Jr has an estimated net worth of $37 Million. This is based on reported shares across multiple companies, which include Atara Biotherapeutics, Inc., CHIMERIX INC, Ikena Oncology, Inc., PTC THERAPEUTICS, INC., Translate Bio, Inc., Akebia Therapeutics, Inc., Cerevel Therapeutics Holdings, Inc., IDENIX PHARMACEUTICALS INC, and KERYX BIOPHARMACEUTICALS INC.
SEC CIK
Ronald C Renaud Jr's CIK is 0001354434
Past Insider Trading and Trends
2021 was Ronald C Renaud Jr's most active year for acquiring shares with 8 total transactions. Ronald C Renaud Jr's most active month to acquire stocks was the month of May. 2021 was Ronald C Renaud Jr's most active year for disposing of shares, totalling 12 transactions. Ronald C Renaud Jr's most active month to dispose stocks was the month of July. 2023 saw Ronald C Renaud Jr paying a total of $2,008,811.21 for 620,429 shares, this is the most they've acquired in one year. In 2021 Ronald C Renaud Jr cashed out on 3,488,749 shares for a total of $36,254,014.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Atara Biotherapeutics, Inc. (ATRA) Snapshot price: $0.9676
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +186.36% | 20.5K |
—
|
—
| 31.5K |
Jun 23
| |||
Form 4
|
∞
| 11K |
—
|
—
| 11K |
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CHIMERIX INC (CMRX) Snapshot price: $0.9198
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ikena Oncology, Inc. (IKNA) Snapshot price: $1.38
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
PTC THERAPEUTICS, INC. (PTCT) Snapshot price: $25.27
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Translate Bio, Inc. No price found
Chief Executive Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -954.05K |
$38.00 | -$36,254,014.00 |
0
|
Sep 14
| |||
Form 4/A
| +1.83% | 9.03K |
$7.39 | $66,702.14 | 503.23K |
Apr 7
| |||
Form 4
| +1.83% | 9.03K |
$7.39 | $66,702.14 | 503.32K |
Apr 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
| +1.15% | 5.64K |
$7.39 | $41,673.16 | 494.2K |
Jan 14
| |||
Form 4
| +12.17% | 53.01K |
$7.39 | $391,724.58 | 488.57K |
Nov 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 8
| |||
Form 4
| +22.17% | 81.82K |
—
|
—
| 450.82K |
Jul 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||